At Stream Bio, we develop and manufacture a range of innovative bioimaging molecular probes that cover the visible and near infra-red spectrum: Conjugated Polymer Nanoparticles (CPNs™), for applications in R&D, in vitro diagnostic assays and therapeutic research. CPNs™ have superior properties to conventional probes, including immense brightness – up to 1000x brighter than Quantum dots – giving greater sensitivity, incredible stability across wide ranges of temperature and pH, and the ability to be linked to a variety of targeting molecules.
Invented in the research labs of King’s College London, Stream Bio was founded as the vehicle through which to demonstrate the wide-ranging benefits and applications of CPNs™. Our approach combines a forward-thinking attitude with a breadth of industry expertise in both science and business, enabling us to create CPN™ solutions for the various strands of the life science industry. Stream Bio’s technology is already making a positive impact on in vivo R&D, diagnostics and therapeutics.